Effect of hydrocortisone on development of shock among patients with severe sepsis the HYPRESS randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 316, Issue 17, 2016, Pages 1775-1785

  Keh, Didier ^a   Trips, Evelyn ^a   Marx, Gernot ^a   Wirtz, Stefan P ^a   Abduljawwad, Emad ^a   Bercker, Sven ^a   Bogatsch, Holger ^a   Briegel, Josef ^a   Engel, Christoph ^a   Gerlach, Herwig ^a   Goldmann, Anton ^a   Kuhn, Sven Olaf ^a   Hüter, Lars ^a   Meier Hellmann, Andreas ^a   Nierhaus, Axel ^a   Kluge, Stefan ^a   Lehmke, Josefa ^a   Loeffler, Markus ^a   Oppert, Michael ^a   Resener, Kerstin ^a   Schädler, Dirk ^a   Schuerholz, Tobias ^a   Simon, Philipp ^a   Weiler, Norbert ^a   Weyland, Andreas ^a   Reinhart, Konrad ^a   Brunkhorst, Frank M ^a   more..

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HYDROCORTISONE; PLACEBO; ANTIINFLAMMATORY AGENT;

ADULT; AGED; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CRITICAL ILLNESS; DELIRIUM; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; GERMANY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUSCLE WEAKNESS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY INFECTION; SEPSIS; SEPTIC SHOCK; SURVIVAL; UNIVERSITY HOSPITAL; CLINICAL TRIAL; COMPLICATION; DISEASE COURSE; DRUG ADMINISTRATION; HOSPITAL MORTALITY; INTENTION TO TREAT ANALYSIS; MIDDLE AGED; MULTICENTER STUDY; SHOCK, SEPTIC; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; DELIRIUM; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSPITAL MORTALITY; HUMANS; HYDROCORTISONE; INTENSIVE CARE UNITS; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; SEPSIS; SHOCK, SEPTIC; TIME FACTORS;

EID: 84997287919     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2016.14799     Document Type: Article

References (40)

1. Patel GP, Balk RA. Systemic steroids in severe sepsis and septic shock. Am J Respir Crit Care Med. 2012;185(2):133-139.
2. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee Including the Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165-228.
3. Annane D, Sille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288(7):862-871.
4. Sprung CL, Annane D, Keh D, et al; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(2):111-124.
5. Marik PE, Pastores SM, Annane D, et al; American College of Critical Care Medicine. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36(6):1937-1949.
6. Sligl WI, Milner DA Jr, Sundar S, MphatsweW, Majumdar SR. Safety and efficacy of corticosteroids for the treatment of septic shock: a systematic review and meta-analysis. Clin Infect Dis. 2009;49 (1):93-101.
7. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for treating sepsis. Cochrane Database Syst Rev. 2015;12(12):CD002243.
8. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005; 171(3):242-248.
9. Blum CA, Nigro N, Briel M, et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2015;385(9977):1511-1518.
10. Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015;313(7):677-686.
11. Siemieniuk RA, Meade MO, Alonso-Coello P, et al. Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis. Ann Intern Med. 2015;163(7):519-528.
12. Bone RC, Balk RA, Cerra FB, et al; ACCP/SCCM Consensus Conference Committee, American College of Chest Physicians/Society of Critical Care Medicine. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101(6):1644-1655.
13. Reinhart K, Brunkhorst F, Bone H, et al; Deutsche Sepsis-Gesellschaft e.V. Diagnosis and therapy of sepsis: guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine [in German]. Anaesthesist. 2006;55(suppl 1):43-56.
14. Brunkhorst FM, Engel C, Bloos F, et al; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358(2):125-139.
15. Pocock SJ. Clinical Trials: A Practical Approach. New York, NY: John Wiley & Sons; 1983.
16. Loisa P, Parviainen I, Tenhunen J, Hovilehto S, Ruokonen E. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial. Crit Care. 2007;11(1):R21.
17. Keh D, Boehnke T,Weber-Cartens S, et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med. 2003; 167(4):512-520.
18. Ely EW, Truman B, Shintani A, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289(22):2983-2991.
19. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). JAMA. 2001; 286(21):2703-2710.
20. Vincent JL, Moreno R, Takala J, et al;Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med. 1996;22(7):707-710.
21. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270(24):2957-2963.
22. KnausWA, Draper EA,Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10): 818-829.
23. Moreno RP,Metnitz PG, Almeida E, et al; SAPS 3 Investigators. SAPS 3-from evaluation of the patient to evaluation of the intensive care unit, part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med. 2005;31(10):1345-1355.
24. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ. 2004;329(7464):480.
25. Bone RC, Fisher CJJ Jr, Clemmer TP, Slotman GJ,Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987; 317(11):653-658.
26. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS,Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA. 1995;273(2):117-123.
27. Vincent JL, Angus DC, Artigas A, et al; Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med. 2003;31(3):834-840.
28. Alberti C, Brun-Buisson C, Goodman SV, et al; European Sepsis Group. Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients. Am J Respir Crit Care Med. 2003;168(1):77-84.
29. Liu VX, Morehouse JW, Marelich GP, et al. Multicenter implementation of a treatment bundle for patients with sepsis and intermediate lactate values. Am J Respir Crit Care Med. 2016;193(11): 1264-1270.
30. Meijvis SC, Hardeman H, Remmelts HH, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;377(9782):2023-2030.
31. Cuthbertson BH, Sprung CL, Annane D, et al. The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med. 2009;35(11):1868-1876.
32. Remmelts HH, Meijvis SC, Heijligenberg R, et al. Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia. J Infect. 2012;65(1):25-31.
33. Kalil AC, Sun J. Low-dose steroids for septic shock and severe sepsis: the use of Bayesian statistics to resolve clinical trial controversies. Intensive Care Med. 2011;37(3):420-429.
34. Steinberg KP, Hudson LD, Goodman RB, et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16): 1671-1684.
35. Roquilly A, Mahe PJ, Seguin P, et al. Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA. 2011;305(12):1201-1209.
36. Cerejeira J, Batista P, Nogueira V, Vaz-Serra A, Mukaetova-Ladinska EB. The stress response to surgery and postoperative delirium: evidence of hypothalamic-pituitary-adrenal axis hyperresponsiveness and decreased suppression of the GH/IGF-1 axis. J Geriatr Psychiatry Neurol. 2013; 26(3):185-194.
37. Plaschke K, Fichtenkamm P, Schramm C, et al. Early postoperative delirium after open-heart cardiac surgery is associated with decreased bispectral EEG and increased cortisol and interleukin-6. Intensive Care Med. 2010;36(12): 2081-2089.
38. Nguyen DN, Huyghens L, Zhang H, Schiettecatte J, Smitz J, Vincent JL. Cortisol is an associated-risk factor of brain dysfunction in patients with severe sepsis and septic shock. Biomed Res Int. 2014;2014:712-742.
39. Schreiber MP, Colantuoni E, Bienvenu OJ, et al. Corticosteroids and transition to delirium in patients with acute lung injury. Crit Care Med. 2014; 42(6):1480-1486.
40. Sau AM, Slooter AJ, Veldhuijzen DS, van Eijk MM, Devlin JW, van Dijk D. Intraoperative dexamethasone and delirium after cardiac surgery: a randomized clinical trial. Anesth Analg. 2014;119 (5):1046-1052.